Antibody engineering at the millennium
- PMID: 10907088
- DOI: 10.2144/00291ov01
Antibody engineering at the millennium
Abstract
It has been almost 100 years since von Behring and Kitasato received the first Nobel prize for the discovery of passive immunotherapy and nearly 25 years since Köhler and Milstein first reported hybridoma technology. In the 15 years since Mullis and co-workers described PCR, a number of discoveries and technologies have converged to produce a renaissance in antibody therapeutics. Our vision of antibodies as tools for research--useful for the prevention, detection and treatment of disease--has been revolutionized by these recent advances. This review specifically focuses on what is now called antibody engineering and includes chimeric and humanized antibodies, immunoglobulin fragments, antibody libraries, antibody fusion proteins and transgenic organisms as bioreactors. As a consequence of refinements in antibody technology, the field of genetically engineered immunoglobulins has matured into an elegant and important drug and reagent development platform.
Similar articles
-
Meeting report from the 'Therapeutic Antibody Technology 95' meeting--not just 'another recombinant antibody meeting'.Immunotechnology. 1996 Feb;2(1):59-63. doi: 10.1016/1380-2933(96)00036-x. Immunotechnology. 1996. PMID: 9373328 No abstract available.
-
Generation and production of engineered antibodies.Mol Biotechnol. 2004 Jan;26(1):39-60. doi: 10.1385/MB:26:1:39. Mol Biotechnol. 2004. PMID: 14734823 Review.
-
Engineered antibodies take center stage.Hum Antibodies. 2001;10(3-4):127-42. Hum Antibodies. 2001. PMID: 11847424 Review.
-
Universal antibody libraries on phage and bacteria.Year Immunol. 1993;7:50-5. Year Immunol. 1993. PMID: 8372512 Review. No abstract available.
-
Immunotherapeutic potential of antibodies produced in plants.Trends Biotechnol. 1995 Dec;13(12):522-7. doi: 10.1016/S0167-7799(00)89016-2. Trends Biotechnol. 1995. PMID: 8595138 Review.
Cited by
-
Peptide-displaying phage technology in glycobiology.Glycobiology. 2012 Mar;22(3):318-25. doi: 10.1093/glycob/cwr140. Epub 2011 Sep 19. Glycobiology. 2012. PMID: 21930649 Free PMC article. Review.
-
Demystified...recombinant antibodies.J Clin Pathol. 2004 Sep;57(9):912-7. doi: 10.1136/jcp.2003.014407. J Clin Pathol. 2004. PMID: 15333649 Free PMC article. Review.
-
Expression of a ricin toxin B subunit: insulin fusion protein in edible plant tissues.Mol Biotechnol. 2010 Feb;44(2):90-100. doi: 10.1007/s12033-009-9217-1. Mol Biotechnol. 2010. PMID: 19898971 Free PMC article.
-
Production and characterization of a human recombinant monoclonal Fab fragment specific for influenza A viruses.Clin Diagn Lab Immunol. 2003 Jul;10(4):680-5. doi: 10.1128/cdli.10.4.680-685.2003. Clin Diagn Lab Immunol. 2003. PMID: 12853404 Free PMC article.
-
Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model.J Immune Based Ther Vaccines. 2003 Aug 13;1(1):2. doi: 10.1186/1476-8518-1-2. J Immune Based Ther Vaccines. 2003. PMID: 12943554 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials